
Headquarters
55 Francisco Street
Suite 200
San Francisco, CA 94133
Email: info@endpointclinical.com
Phone: 1 (415) 229-1600
A typical drug development cycle can take a decade or more to process a new drug from discovery, through the trial phases to launch. In the post-COVID-19 world, we see disruptive innovation, inspiring a change in momentum to create new therapies quickly and efficiently from discovery to launch. Historically, pharma has taken a highly conservative approach to new technologies and strategies to limit risk, and the regulatory space has constrained innovation to ensure the safety of patients and the quality of the data. Recently, regulatory officials have created new guidelines to advance clinical trials for treatment. These factors are driving breakthrough innovation in pharma that will increase speed and accuracy to move the processes from 10-15 years to 18 months!
Key innovation disruptors include:
Contact us to discuss this topic further, and connect with our thought leader, Catherine Hall, on LinkedIn.
Headquarters
55 Francisco Street
Suite 200
San Francisco, CA 94133
Email: info@endpointclinical.com
Phone: 1 (415) 229-1600
701 Edgewater Drive
Suite 320
Wakefield, MA 01880
820 Davis Street
Suite 452
Evanston, IL 60201
Europe Office
Quartermile One
15 Lauriston Place
Edinburgh EH3 9EP
V Ascendas IT Park
Capella Building, 5th Floor
Plot #17 Software Units Layout
Madhapur, Hyderabad
500081
Telagana, India
Phone: 0008004430028 Ext, 7507
Call us from within the United States:
Calling from outside the United States?
For answers to common problems, visit our support desk or email them at support@endpointclinical.com.